The reliability of thrombotic tendency measured by intravascular wires in the rat

Thrombosis Research

Volumn 87, Issue 4, 1997, Pages 353-357

  Lavelle, S M ^a   Iomhair, Maura Mhic ^a  

^a NONE

Author keywords

Experimental thrombosis; Hypercoagulability; Platinum wire; Rats; Reproducibility; Thrombosis activation

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; PLATINUM;

ABDOMINAL AORTA; ANIMAL MODEL; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; EXPERIMENTAL MODEL; FEMALE; FOREIGN BODY; HYPERCOAGULABILITY; INFERIOR CAVA VEIN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; THROMBOGENESIS; THROMBOSIS; VEIN THROMBOSIS;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; MALE; RATS; RATS, SPRAGUE-DAWLEY; THROMBOSIS;

EID: 0030866685     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00138-2     Document Type: Article

References (15)

1. HENRY R.L. Methods for inducing experimental thrombosis. Angiology 13, 554-577, 1962.
2. BIZZOZERO J. Ueber einen neuen formbestandtheil des blutes und dessen rolle bei der thrombose und der blutgerinnung. Arch. Pathol. Anat. 90, 261-332, 1882.
3. SISE H.S., MOSCHOS C.B., BECKER R. On the nature of hypercoagulability Am. J. Med. 33, 667-678, 1962.
4. OLSON P.S., LJUNGQVIST U., BERGENTZ S.E. Thrombus formation in stainless steel tubes used as vascular implants in the dog. Thromb. Res., 4, 271-283, 1974
5. SCHAFER A.I. The hypercoagulable states. Ann. Intern. Med. 102, 814-828, 1985.
6. SHOENFELD N.A., YEAGER A., CONNOLLY R., RAMBERG K., FORGIONE L., GIORGIO A., VALERI C.R., CALLOW A.D. A new primate model for the study of intravenous thrombotic potential and its modification. J. Vasc. Surg., 8 ,49-54, 1988.
7. LAVELLE S.M., Mac IOMHAIR M. The quantitative reduction by heparin of intravenous thrombosis in normal and hypercoagulable animals. Ir. J. Med. Sci. 149, 266-269, 1980.
8. Mac IOMHAIR M., LAVELLE SM. Thrombus weight as a measure of hypercoagulability induced by drugs. Thrombos. Haemostas. 42, 1018-1021, 1979.
9. EMMS H., LEWIS G.P. The effect of synthetic ovarian hormones on an in vivo model of thrombosis in the rat. Br. J. Pharmacol. 84, 243-248, 1985.
10. ARNARDER C., PASCHE B., KODAMA K., RASMUSON A., OLSSON P. Influence of high and low wall shear rates on the inhibition of factor Xa and thrombin at surfaces coated with immobilised heparin. Artif. organs 13, 521-526, 1989.
11. ISRAEL D.H, FUSTER V., CHESEBRO J.H., BADIMON L. Antithrombotic therapy for coronary artery disease and valvular heart disease. In: Hirsh J ed. Bailliere's Clinical Haematology. London:Bailliere Tindall pp705-743,1990.
12. SMITH L.J., SCHAIBLE K.L., FESSLER R.G., RACHLIN J.R., BROWN F.D. Examination of the utility of the rat as an animal model for human anticoagulation. Haemostasis 17, 206-210, 1987
13. MAC IOMHAIR M., LAVELLE S.M. The anticoagulant, antithrombotic and haemorrhagic effect of long-term warfarin on experimental venous and arterial thrombosis in the rat. Irish J. Med. Sci. 165 , 213-220, 1996.
14. MAC IOMHAIR M., LAVELLE S.M. Effect of aspirin-dipyridamole and heparin and their combination on venous thrombosis in hypercoagulable or thrombotic animals. Thromb. Res. 82, 479-483,1996.
15. Thrombosis Research, Vol. 87, No. 4, pp. 359-362, 1997